Annual General Meeting
April 28, 2017
1 2 0 1 7 A N N U A L G E N E R A L M E E T I N G
Annual General Meeting April 28, 2017 Eva Carissimi President & - - PowerPoint PPT Presentation
Annual General Meeting April 28, 2017 Eva Carissimi President & CEO Mike Boone - CFO 2 0 1 7 A N N U A L G E N E R A L M E E T I N G 1 Forward-Looking Statements This presentation contains forward-looking statements and
1 2 0 1 7 A N N U A L G E N E R A L M E E T I N G
This presentation contains forward-looking statements and forward-looking information within the meaning of applicable securities
“intends”, “estimates”, “are expected”, “is forecast”, “approximately” or variations of such words and phrases, or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or words and expressions
business plans and operation of the Processing Facility, Net Revenues under market terms, the sensitivity of Net Revenues under market terms, the sale of zinc metal inventory, future liabilities and obligations of the Fund (including capital expenditures), the ability of the Fund to operate profitably after the expiry of the initial term of the Supply and Processing Agreement in May 2017, the dependence upon the continuing supply of zinc concentrates and competition relating thereto, the ability of the Processing Facility to treat a more varied feed quality stream, anticipated trends in zinc concentrate supply and demand, zinc concentrate treatment charges, the anticipated financial and operating results of the Fund and distributions to Unitholders. The Fund provides this information because they are the key drivers of the business. Readers are cautioned that this information may not be appropriate for other reasons. These statements and information are based, among others, on the Fund’s current assumptions, expectations, estimates,
the Fund operates or which could affect the Fund’s activities, the Fund’s ability to attract and retain clients and consumers as well as the Fund’s operating costs, raw materials and energy supplies, all of which are subject to a number of risks and uncertainties. Forward-looking information involves known and unknown risks, uncertainties and other factors, which may cause the actual events, results or performance to be materially different from any future events, results or performance expressed or implied by the forward-looking statements and information. As a result, the Fund cannot guarantee that any forward-looking statements will
cause the Fund’s actual events, results or performance to differ materially from the Fund’s current expectations are discussed throughout this document and in our other continuous disclosure materials available on SEDAR at www.sedar.com. Examples of such risks, uncertainties and other factors include, but are not limited to: (1) the Fund’s ability to operate at normal production levels and to generate sufficient income, including because of the ongoing strike of the employees at the Processing Facility, and to make distributions; (2) the demand and price for zinc concentrate, zinc metal, sulphuric acid and copper in cake; (3) dependence upon the continuing supply of zinc concentrates and the terms of that supply; (4) the ability to manage sulphuric acid inventories; (5) changes in future zinc concentrate, zinc grade and impurity levels and their potential impact on capital expenditure and working capital requirements, operating costs, production and recoveries;
2 0 1 7 A N N U A L G E N E R A L M E E T I N G
2
(6) changes to the supply and demand for specific zinc metal products and the impact on the Fund’s realized premiums; (7) reliance on Glencore Canada and certain of its affiliates for sales agency services and the management, operation and maintenance of the Processing Facility, the Fund, the Operating Trust (including credit support in connection with the ABL Facility) and the Partnership, and reliance on the performance and operations of the Processing Facilities as the Fund’s sole operating asset; (8) the ability of the Fund to continue to service customers in the same geographic region and the Fund’s dependence on key customers; (9) general business and economic conditions and the condition of financial and credit markets; (10) legislation and regulations governing the operation of the Fund including, without limitation, air emissions, discharges into water, waste including residue ponds, hazardous materials, workers’ health and safety, and many other aspects of the Fund’s operations, as well as the impact of current and future legislation and regulations on expenses, capital expenditures, taxation and restrictions on the operation of the Processing Facility; (11) loan default and refinancing risk associated with the ABL Facility; (12) the impact of costs and liabilities related to the closure, decommissioning, reclamation and rehabilitation of the Processing Facility and surrounding lands, including employee severance, pensions, and environmental and reclamation and rehabilitation liabilities if an acceptable replacement arrangement is not put in place after the expiration of the Supply and Processing Agreement; (13) the sensitivity of the Fund’s Net Revenues to reductions in realized zinc metal prices including premiums, copper prices, sulphuric acid prices; and the strengthening of the Canadian dollar vis-à-vis the US dollar; (14) the sensitivity of the Fund’s production costs to increases in electricity rates, other energy costs, labour costs and operating supplies used in its operations, and the sensitivity
regulatory investigations, claims, lawsuits and other proceedings; and (16) increasing transportation, labour and distribution costs; (17) changes in recoveries, reserves and capital expenditure requirements and risks of closure and decommissioning and related liabilities in respect of the Processing Facility; (18) changes in income tax laws and other risks associated with the Fund continuing as a taxable income trust; (19) transportation disruptions; and (20) the other general risks and uncertainties set out in the Fund’s continuous disclosure documents on file with the Canadian Securities Regulatory Authorities. Forward-looking information contained in this presentation is based on management’s current estimates, expectations and assumptions, which management believes are reasonable as of the current date. You should not place undue importance on forward-looking information and should not rely upon this information as of any other date. Except as required by law, the Fund does not undertake to update these forward-looking statements, whether written or oral, that may be made from time to time by the Fund or on the Fund’s behalf. All dollar amounts are in Canadian, except otherwise noted.
3 2 0 1 7 A N N U A L G E N E R A L M E E T I N G
4 2 0 1 7 A N N U A L G E N E R A L M E E T I N G
5
2 0 1 7 A N N U A L G E N E R A L M E E T I N G
2 0 1 7 A N N U A L G E N E R A L M E E T I N G 6
2 0 1 7 A N N U A L G E N E R A L M E E T I N G 7
2 0 1 7 A N N U A L G E N E R A L M E E T I N G 8
2 0 1 7 A N N U A L G E N E R A L M E E T I N G 9
67,627 50,048 Q1 2016 Q1 2017
72,639 49,516 Q1 2016 Q1 2017
workers’ strike
production levels
metal production
10
2 0 1 7 A N N U A L G E N E R A L M E E T I N G
2 0 1 7 A N N U A L G E N E R A L M E E T I N G 11
$80.4 $43.9 Q1 2016 Q1 2017
$CDN Millions
*Adjusted Net Revenues means revenues less raw material purchase costs (“Net Revenues”) excluding unrealized concentrate settlement adjustments and after foreign exchange gain/loss and derivative financial instruments gain/loss.
Q1 2017 results impacted by:
$CDN Millions $4.4 $5.4 Q1 2016 Q1 2017
Q1 2017 results impacted by:
2 0 1 7 A N N U A L G E N E R A L M E E T I N G
Before Working Capital Changes* $CDN Millions
12
After Working Capital Changes * $CDN Millions
Results impacted:
$69.4
Q1 2016 Q1 2017 $28.1 $2.6 Q1 2016 Q1 2017
* Before distributions
13
$2.3 Copper Sulphuric Acid $4.0
production and lower by-product sales
$1.4 Copper Sulphuric Acid $0.9
2 0 1 7 A N N U A L G E N E R A L M E E T I N G
14
$CDN Millions
2 0 1 7 A N N U A L G E N E R A L M E E T I N G
Key Q1 2017 investments
$4.2 $5.1 Q1 2016 Q1 2017 $CDN Millions
15
5 10 15 20 25 30 Cash flow from
WC changes and Distributions - 2016 Volume Price FX Derivative financial instruments Costs Income taxes Inventory margin and other Cash flow from
WC changes and Distributions - 2017
$5.7M ($0.6M) ($9.4M) ($6.0M) $2.6M $28.1M ($1.5M) ($13.1M) ($0.6M)
* Before non-cash working capital changes and cash distributions
2 0 1 7 A N N U A L G E N E R A L M E E T I N G
2 0 1 7 A N N U A L G E N E R A L M E E T I N G 16
2 0 1 7 A N N U A L G E N E R A L M E E T I N G 17
18
2 0 1 7 A N N U A L G E N E R A L M E E T I N G
19
2 0 1 7 A N N U A L G E N E R A L M E E T I N G
20
2 0 1 7 A N N U A L G E N E R A L M E E T I N G
2 0 1 7 A N N U A L G E N E R A L M E E T I N G
Products Clients
NIF pays 96% of zinc contained in concentrate less fixed treatment charge (in CDN$). Treatment charge adjusted upwards annually NIF pays 96% of zinc contained in concentrate but recovers 97%, resulting in metal gain of 1 %. NIF receives premium to LME price based on shapes/alloys/regional demand. By-products sold by GCC at market prices.
Treatment charges
Recovery Zinc premiums By-products
NIF pays approx 85% of zinc contained in concentrate less treatment charge per tonne of concentrate (in USD). Treatment charge negotiated annually based on market conditions. NIF pays approx 85% of contained zinc in concentrate and recovers 97%, resulting in metal gain of 12%. NIF to receive market- based premiums. For 12 month period, premium will be fixed.
S P A M A R K E T
By-products sold by GCC at market prices.
Processing facility Concentrate
20
22 2 0 1 7 A N N U A L G E N E R A L M E E T I N G
Existing Supply and Processing Agreement 12 month fixed fee based on market terms agreement with Glencore
Market terms and assumptions used for this calculation: Average 2017 Zinc price US$1.26; Cdn/US exchange rate $1.32; Market payable metal in concentrate 85%; Zinc metal sales 49,516 tonnes; Zinc metal recovery 96.9% * Adjusted EBITDA is used by the Fund as an indication of cash generated from operations. Adjusted EBITDA is not a recognized measure under IFRS and therefore the Fund’s method of calculating Adjusted EBITDA is unlikely to be comparable to methods used by other entities.
23
2 0 1 7 A N N U A L G E N E R A L M E E T I N G
2 0 1 7 A N N U A L G E N E R A L M E E T I N G 24
2 0 1 7 A N N U A L G E N E R A L M E E T I N G 25